Bicalutamide Injection

                                                          Mesotherapy with Antiandrogen: Bicalutamide

Product Overview·

BICALUTAMIDE 0.5% IN LIPOSOMES

Selective Androgen Receptor Blocker for Targeted Hair Loss Therapy

In androgenetic alopecia, hair follicles exhibit increased sensitivity to androgens despite normal circulating hormone levels. Bicalutamide is a non-steroidal, selective androgen receptor antagonist that blocks androgen binding at the follicular level, preventing DHT-mediated damage. Liposomal delivery allows localized action with minimal systemic absorption.

 Key Benefits

· Blocks androgen receptor activation at the follicular level

· Reduces follicular sensitivity to DHT

· Supports hair regrowth and maintenance of hair density

· Suitable alternative for patients intolerant to oral anti-androgens

· Minimal systemic exposure when administered via mesotherapy

· Provides synergistic benefits when combined with dutasteride

Key Mechanism & Role

· Bicalutamide

· Selective androgen receptor antagonist

· Inhibits DHT-mediated intracellular signalling

· Helps preserve hair shaft thickness and follicular integrity

· Complements 5-alpha reductase inhibition for enhanced outcomes

 Recommended Usage Guidelines

· Mesotherapy sessions every 15 days, or as directed by the treating physician.

· Effectively reduces scalp DHT levels

· Slows progression of follicular miniaturization

· Promotes thicker, stronger hair regrowth

· Demonstrates superior efficacy compared to finasteride

· Long half-life ensures sustained therapeutic effect

· Well tolerated in mesotherapy with reduced systemic side effects

Key Mechanism & Role

Dutasteride

· Dual inhibition of Type I & II 5-alpha reductase

· Prevents conversion of testosterone to DHT

· Prolongs the anagen (growth) phase of the hair cycle

· Improves hair density and follicle longevity in AGA

Recommended Usage Guidelines

Mesotherapy sessions every 1–2 months, or as directed by the treating physician.